18F-FDG uptake in lung, breast, and colon cancers: molecular biology correlates and disease characterization

H Jadvar, A Alavi, SS Gambhir - Journal of Nuclear Medicine, 2009 - Soc Nuclear Med
It is hoped that in the not too distant future, noninvasive imaging–based molecular
interrogation and characterization of tumors can improve our fundamental understanding of …

Fundamentals of PET and PET/CT imaging

S Basu, TC Kwee, S Surti, EA Akin… - Annals of the New …, 2011 - Wiley Online Library
In this review, the fundamental principles of fluorodeoxyglucose (FDG) positron emission
tomography (PET) and FDG PET/computed tomography (CT) imaging have been described …

Comparison of triple‐negative and estrogen receptor‐positive/progesterone receptor‐positive/HER2‐negative breast carcinoma using quantitative fluorine‐18 …

S Basu, W Chen, J Tchou, A Mavi… - … Journal of the …, 2008 - Wiley Online Library
BACKGROUND. This study was designed to investigate the fluorine‐18 fluorodeoxyglucose
(FDG)‐positron emission tomography (PET) imaging characteristics of triple‐negative …

Reproducibility of standardized uptake value measurements determined by 18F-FDG PET in malignant tumors

C Nahmias, LM Wahl - Journal of Nuclear Medicine, 2008 - Soc Nuclear Med
18F-FDG PET is increasingly being used to monitor the early response of malignant tumors
to chemotherapy. Understanding the reproducibility of standardized uptake values (SUVs) is …

When should we recommend use of dual time-point and delayed time-point imaging techniques in FDG PET?

G Cheng, DA Torigian, H Zhuang, A Alavi - European journal of nuclear …, 2013 - Springer
Abstract FDG PET and PET/CT are now widely used in oncological imaging for tumor
characterization, staging, restaging, and response evaluation. However, numerous benign …

The pivotal role of FDG-PET/CT in modern medicine

S Hess, BA Blomberg, HJ Zhu, PF Høilund-Carlsen… - Academic radiology, 2014 - Elsevier
The technology behind positron emission tomography (PET) and the most widely used
tracer, 2-deoxy-2-[18F] fluoro-D-glucose (FDG), were both conceived in the 1970s, but the …

FDG PET/CT of primary bone tumors

CM Costelloe, HH Chuang… - American Journal of …, 2014 - Am Roentgen Ray Soc
OBJECTIVE. Numerous primary bone tumors are encountered on 18F-FDG PET/CT, and
many are FDG avid. The degree of FDG uptake in bone tumors does not necessarily reflect …

[18F]fluoromethylcholine (FCH) positron emission tomography/computed tomography (PET/CT) for lymph node staging of prostate cancer: a prospective study of 210 …

MH Poulsen, K Bouchelouche… - BJU …, 2012 - Wiley Online Library
Study Type–Diagnostic (exploratory cohort) Level of Evidence 2a What's known on the
subject? and What does the study add? Staging of patients with prostate cancer is the …

PET tumor metabolism in locally advanced breast cancer patients undergoing neoadjuvant chemotherapy: value of static versus kinetic measures of …

LK Dunnwald, RK Doot, JM Specht, JR Gralow… - Clinical Cancer …, 2011 - AACR
Purpose: Changes in tumor metabolism from positron emission tomography (PET) in locally
advanced breast cancer (LABC) patients treated with neoadjuvant chemotherapy (NC) are …

[HTML][HTML] Positron emission mammography in breast cancer presurgical planning: comparisons with magnetic resonance imaging

K Schilling, D Narayanan, JE Kalinyak, J The… - European journal of …, 2011 - Springer
Purpose The objective of this study was to compare the performance characteristics of 18 F-
fluorodeoxyglucose (FDG) positron emission mammography (PEM) with breast magnetic …